A Clinical Study to Test Long Term Safety of GLPG1690 for Patients With Systemic Sclerosis
Public ClinicalTrials.gov record NCT03976648. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Open-label Extension Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Orally Administered GLPG1690 in Subjects With Systemic Sclerosis
Study identification
- NCT ID
- NCT03976648
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Lakefront Biotherapeutics NV
- Industry
- Enrollment
- 31 participants
Conditions and interventions
Conditions
Interventions
- GLPG1690 Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 17, 2019
- Primary completion
- Apr 12, 2021
- Completion
- Apr 12, 2021
- Last update posted
- Mar 28, 2022
2019 – 2021
United States locations
- U.S. sites
- 6
- U.S. states
- 4
- U.S. cities
- 5
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pacific Arthritis Care Center | Los Angeles | California | 90045 | — |
| UCLA Rheumatology | Los Angeles | California | 90095 | — |
| RASF Clinical Research Center | Boca Raton | Florida | 33486 | — |
| University of Michigan | Ann Arbor | Michigan | 48109 | — |
| Metroplex Clinical Research Center | Dallas | Texas | 75231 | — |
| UT Physicians Center for Autoimmunity | Houston | Texas | 77030 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 8 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03976648, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 28, 2022 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03976648 live on ClinicalTrials.gov.